ForbesThe Cannabis Crossroads: How Schedule III and The Farm Bill IntersectMay 3Robert HobanBy Robert Hobanmore_vert
The New York TimesSenate Democrats Reintroduce Legislation to Legalize MarijuanaMay 1Kayla GuoBy Kayla Guomore_vert
ReutersPot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drugApr 30Tanay DhumalBy Tanay Dhumalmore_vert
The Washington PostDemocrats hope move to reschedule marijuana will help them in NovemberMay 1Michael Scherer, Tyler Pager & Fenit NirappilBy Michael Scherer, Tyler Pager & Fenit Nirappilmore_vert
Oregon Public BroadcastingFederal cannabis reclassification could bring pharmaceutical companies to Oregon’s marijuana industryMay 1Geoff NorcrossBy Geoff Norcrossmore_vert
Marijuana MomentRescheduling Cannabis Shifts The Paradigm By Finally Recognizing Its Medical Value (Op-Ed)May 1Shawn HauserBy Shawn Hausermore_vert
The AtlanticMarijuana’s Health Effects Are About to Get a Whole Lot ClearerMay 3Jeremy BerkeBy Jeremy Berkemore_vert
CNNJustice Dept plans to reschedule marijuana as a lower-risk drugApr 30Alicia Wallace, Jeff Zeleny & Kevin LiptakBy Alicia Wallace, Jeff Zeleny & Kevin Liptakmore_vert
The Motley FoolWhy Canopy Growth, Tilray, and Cronos Group Stocks Just CrateredMay 1Rich SmithBy Rich Smithmore_vert
CNBCCannabis stocks surge as Biden administration moves to reclassify marijuanaApr 30Darla MercadoBy Darla Mercadomore_vert
Los Angeles TimesEditorial: Reclassifying marijuana is not decriminalization, but is a welcome step in that directionMay 1more_vert
The Wall Street JournalBiden Administration Aims to Reclassify Marijuana as Less Dangerous DrugApr 30Sadie Gurman & Liz Essley WhyteBy Sadie Gurman & Liz Essley Whytemore_vert
InvestorPlace3 Hot Cannabis Stocks With Multibagger Return Potential Before the Presidential ElectionApr 30Faisal HumayunBy Faisal Humayunmore_vert
MedscapeThe DEA Plans to Reschedule Marijuana: What Happens Next?May 2Kelli Whitlock BurtonBy Kelli Whitlock Burtonmore_vert
POLITICOBiden administration weakens weed restrictions, backtracking from decades of policiesApr 30Natalie FertigBy Natalie Fertigmore_vert
Sky NewsUS plans to reclassify cannabis as less dangerous drugApr 30Reemul BallaBy Reemul Ballamore_vert
Rolling StoneIs the Biden Administration’s Pot Decision Historic — Or Half-Baked?May 1Tim DickinsonBy Tim Dickinsonmore_vert
NewsweekMarijuana Reclassification Puts Politics and Profits Ahead of Public HealthMay 2Kevin SabetBy Kevin Sabetmore_vert
Mother JonesReport: The DEA Is Finally Reclassifying Pot as Less DangerousApr 30Julia MetrauxBy Julia Metrauxmore_vert
The Denver Post“A big deal”: What the feds’ move to reclassify marijuana means for Colorado cannabisApr 30Tiney RicciardiBy Tiney Ricciardimore_vert
Cannabis Business TimesUPDATE: DEA Moves to Reschedule CannabisApr 30Tony Lange, Noelle Skodzinski & Michelle SimakisBy Tony Lange, Noelle Skodzinski & Michelle Simakismore_vert
Marijuana Business DailyDEA signs off on marijuana rescheduling, report says, but process not done yetApr 30Chris RobertsBy Chris Robertsmore_vert
NBC NewsBiden administration plans to reclassify marijuana, easing restrictions nationwideApr 30Julie Tsirkin & Monica AlbaBy Julie Tsirkin & Monica Albamore_vert
Fox NewsBiden admin will move to reclassify marijuana as 'less dangerous drug' in historic shiftApr 30Stepheny PriceBy Stepheny Pricemore_vert
USA TODAYBiden administration plans to drastically change federal rules on marijuanaApr 30Eduardo Cuevas, Jeanine Santucci & Michael CollinsBy Eduardo Cuevas, Jeanine Santucci & Michael Collinsmore_vert
The HillBiden administration plans to ease marijuana restrictionsApr 30Lauren Irwin & Joseph ChoiBy Lauren Irwin & Joseph Choimore_vert
LeaflyPresident Biden announces marijuana will move to Schedule IIIApr 30Max Savage LevensonBy Max Savage Levensonmore_vert
ABC NewsDEA plans to back reclassifying marijuana as less serious drug, sources sayApr 30Mary Bruce, Luke Barr & Justin Ryan GomezBy Mary Bruce, Luke Barr & Justin Ryan Gomezmore_vert
BenzingaCannabis Stocks React To DEA Rescheduling: Canopy & Aurora Surge, Tilray, WM Tech Hold Steady - Aurora ...Apr 30more_vert
NPRBiden moves to reclassify marijuana and lessen restrictionsApr 30Deepa ShivaramBy Deepa Shivarammore_vert
High TimesCannabis Community, Investors React to DEA Decision To RescheduleMay 2A.J. HerringtonBy A.J. Herringtonmore_vert
BBC.comUS moves to reclassify marijuana in historic shiftApr 30Bernd Debusmann Jr. & Bernd DebusmannBy Bernd Debusmann Jr. & Bernd Debusmannmore_vert
CNETWhich States Have Legalized Marijuana for Recreational or Medical Use?May 4Peter ButlerBy Peter Butlermore_vert
The Associated PressNew era for pot regulation leaves old problem: Many cannabis companies can't find a bankMay 1Michael BloodBy Michael Bloodmore_vert
The Associated PressBiden’s historic marijuana shift is his latest election year move for young votersMay 1Jonathan J. CooperBy Jonathan J. Coopermore_vert
Los Angeles TimesDEA's big marijuana shift could be a lifeline for California's troubled pot industryMay 1Salvador HernandezBy Salvador Hernandezmore_vert
ForbesCannabis ETFs Soar On Reports DEA Plans To Reclassify MarijuanaMay 1Lawrence CarrelBy Lawrence Carrelmore_vert
The Wall Street JournalReclassifying Cannabis Still Leaves Pot Stocks in LimboMay 1Carol RyanBy Carol Ryanmore_vert
ReutersUS Justice Department takes step to make marijuana use a less serious crimeApr 30Pratik Jain, Sarah Lynch & Jeff MasonBy Pratik Jain, Sarah Lynch & Jeff Masonmore_vert
HuffPostDEA Moving Toward Recategorizing Marijuana As A Lower-Schedule Drug: ReportsApr 30Jessica Schulberg & Lydia O'ConnorBy Jessica Schulberg & Lydia O'Connormore_vert
The Washington PostWhat marijuana reclassification means and the effects of reschedulingMay 1Fenit NirappilBy Fenit Nirappilmore_vert
ForbesDEA Agrees To Reclassify Marijuana Under Federal Law, AP ReportsApr 30A.J. HerringtonBy A.J. Herringtonmore_vert
The New York TimesBiden Loosens Up on WeedMay 2Zolan Kanno-Youngs, Elisheba Ittoop & Michael BarbaroBy Zolan Kanno-Youngs, Elisheba Ittoop & Michael Barbaromore_vert
The New York TimesThe Cannabis Industry Hopes for New HighsMay 1Michael de la Merced, Andrew Ross Sorkin & Sarah KesslerBy Michael de la Merced, Andrew Ross Sorkin & Sarah Kesslermore_vert